These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6223820)

  • 1. Complete regression of multiple pulmonary metastases in a patient with advanced renal cell carcinoma treated by occlusion of the renal artery with subsequent radical nephrectomy and progesterone.
    Dreikorn K; Terwey B; Drings P; Horsch R; Palmtag H; Rössler W
    Eur Urol; 1983; 9(4):254-6. PubMed ID: 6223820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complete regression of skeletal metastases from hypernephroma after angioinfarction and medroxyprogesterone acetate therapy.
    Amin R
    Urology; 1988 Sep; 32(3):254-8. PubMed ID: 2970709
    [No Abstract]   [Full Text] [Related]  

  • 3. [Spontaneous remission of lung metastases in renal cell carcinoma].
    Müller GA; Diem U; Fritz U; Walter E; Waller HD
    Dtsch Med Wochenschr; 1989 Mar; 114(11):420-3. PubMed ID: 2523299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postoperative prophylactic use of progesterone in renal cell carcinoma.
    Satomi Y; Takai S; Kondo I; Fukushima S; Furuhata A
    J Urol; 1982 Nov; 128(5):919-22. PubMed ID: 6217352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infarction-nephrectomy for metastatic renal carcinoma. Southwest oncology group study.
    Gottesman JE; Crawford ED; Grossman HB; Scardino P; McCracken JD
    Urology; 1985 Mar; 25(3):248-50. PubMed ID: 3156442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medroxyprogesterone in metastatic renal cell carcinoma.
    Rao MK; Soloway MS
    South Med J; 1980 Feb; 73(2):247-8. PubMed ID: 7355330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjunctive medroxyprogesterone acetate to radical nephrectomy in category M0 renal cell carcinoma. Preliminary report of a prospective randomized trial.
    Pizzocaro G; Di Fronzo G; Piva L; Salvioni R; Ronchi E; Cappelletti V; Giongo A; Mastroberardino E; Cozzoli C; Dormia E; Minervini S; Zanollo A; Fontanella U; Giannoni R; Maggioni A; Lasio E
    Eur Urol; 1983; 9(4):202-6. PubMed ID: 6223819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Embolization and subsequent nephrectomy in metastatic renal cell carcinoma.
    Kurth KH; Cinqualbre J; Oliver RT; Schulman CC
    Prog Clin Biol Res; 1984; 153():423-36. PubMed ID: 6206510
    [No Abstract]   [Full Text] [Related]  

  • 9. Angioinfarction plus nephrectomy for metastatic renal cell carcinoma--an update.
    Swanson DA; Johnson DE; von Eschenbach AC; Chuang VP; Wallace S
    J Urol; 1983 Sep; 130(3):449-52. PubMed ID: 6887354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal cell carcinoma--angioinfarction.
    Mebust WK; Weigel JW; Lee KR; Cox GG; Jewell WR; Krishnan EC
    J Urol; 1984 Feb; 131(2):231-5. PubMed ID: 6199518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of renal cell carcinoma with renal infarction, delayed nephrectomy, medroxyprogesterone, and xenogeneic immune RNA.
    Weigel JW; Mebust WK; Foret JD; Noble MJ; Votapka T; Krishnan EC; Jewell WR
    Urology; 1985 Feb; 25(2):103-5. PubMed ID: 3969752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spontaneous regression of renal cell carcinoma metastases after preoperative embolization of primary tumor and subsequent nephrectomy.
    Mohr SJ; Whitesel JA
    Urology; 1979 Jul; 14(1):5-8. PubMed ID: 452221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose medroxyprogesterone acetate in patients with renal adenocarcinoma and measurable lung metastases: a phase II study.
    Kjaer M; Frederiksen PL
    Cancer Treat Rep; 1986 Mar; 70(3):431-2. PubMed ID: 2937534
    [No Abstract]   [Full Text] [Related]  

  • 14. [A case of renal cell carcinoma effectively treated by interferon-alpha and embolization of the renal artery].
    Tsujimura A; Imazu T; Nishimura K; Sugao H; Oka T; Takaha M; Takeda M; Kurata A
    Hinyokika Kiyo; 1993 Nov; 39(11):1039-42. PubMed ID: 8266872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Embolization and postinfarction nephrectomy in patients with primary metastatic renal adenocarcinoma.
    Kurth KH; Debruyne FM; Hall RR; Denis L; Verbaes A; Bollack C; de Voogt HJ; de Pauw M; Silvester R
    Eur Urol; 1987; 13(4):251-5. PubMed ID: 3653165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Regressions of pulmonary metastases of clear cell carcinoma after nephrectomy and progestogen therapy].
    Frea B; Tizzani A; Tasso M
    Minerva Urol; 1981; 33(2):97-101. PubMed ID: 7322102
    [No Abstract]   [Full Text] [Related]  

  • 17. [Complete regression of pulmonary metastases from renal cell carcinoma induced by medroxyprogesterone and streptococcal preparation: a case presentation].
    Nagakura K; Takao M; Matsuzaki S; Ieda K
    Nihon Hinyokika Gakkai Zasshi; 1985 Dec; 76(12):1909-13. PubMed ID: 2940397
    [No Abstract]   [Full Text] [Related]  

  • 18. Management of renal carcinoma--a questionnaire survey.
    Ritchie AW; Chisholm GD
    Br J Urol; 1983 Dec; 55(6):591-4. PubMed ID: 6652423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant medroxyprogesterone acetate to radical nephrectomy in renal cancer: 5-year results of a prospective randomized study.
    Pizzocaro G; Piva L; Di Fronzo G; Giongo A; Cozzoli A; Dormia E; Minervini S; Zanollo A; Fontanella U; Longo G
    J Urol; 1987 Dec; 138(6):1379-81. PubMed ID: 2824861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant medroxyprogesterone acetate and steroid hormone receptors in category M0 renal cell carcinoma. An interim report of a prospective randomized study.
    Pizzocaro G; Piva L; Salvioni R; Di Fronzo G; Ronchi E; Miodini P
    J Urol; 1986 Jan; 135(1):18-21. PubMed ID: 2934557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.